Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.
about
P1343
Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomasA new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cellsDengue Virus Replicon Expressing the Nonstructural Proteins Suffices To Enhance Membrane Expression of HLA Class I and Inhibit Lysis by Human NK CellsNK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival.A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor.CD160 is essential for NK-mediated IFN-γ productionTumor necrosis factor superfamily in innate immunity and inflammation.Identification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cells.A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell linesIncreased CD160 expression on circulating natural killer cells in atherogenesis.The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulationIdentification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation.The canonical and unconventional ligands of the herpesvirus entry mediatorCD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cellsIdentification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytesHuman decidual NK cells: unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies.CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia.Differential and tumor-specific expression of CD160 in B-cell malignancies.HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation.Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes.Reassessment of HLA-G isoform specificity of MEM-G/9 and 4H84 monoclonal antibodies.Porphyromonas gingivalis Lipopolysaccharide Induced Proliferation and Activation of Natural Killer Cells in Vivo.2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells.The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors.CD160 isoforms and regulation of CD4 and CD8 T-cell responses.Mechanistic Sharing Between NK Cells in ABMR and Effector T Cells in TCMR.Expansion of CD4 phenotype among CD160 receptor-expressing lymphocytes in murine pregnancy.Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T-lymphocyte subset in normal and mycosis fungoides skin.Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1.Prognostic values of the mRNA expression of natural killer receptor ligands and their association with clinicopathological features in breast cancer patients.
P2860
Q24299504-63C32CE4-D444-428C-9357-B2B9B7A31970Q26849476-F3B01C3F-E51D-41D8-B1CB-559E9ABC3916Q27309991-D7FC5452-7873-403D-93C8-EDA6745D17A5Q27486580-8E88A9D2-0FD7-46FD-B1E5-0CAFF09363FDQ33741498-2CF2DC77-B58D-489E-9C33-FBB3FF2D0C39Q34673098-386FF0C8-F4C7-4C74-8BD0-36DFB81521A9Q34973743-88F18474-F423-4D37-998E-F17E31560611Q35161483-0C0B8625-0D66-40FE-BFB5-DD9C764F5166Q35245316-96D5B02D-A74F-49C6-96CE-F66BB57FFF17Q35588890-494A1AF8-1DB9-40B1-B4DB-B0A032165A72Q35626593-8763F36B-4A8A-4B65-B772-85B45C3BAECEQ35743284-04CBE0D4-B732-49F5-A72D-2B1CDF50139AQ36053977-C2A7EA78-E99B-4A8D-BD9A-D7F9CE56FB17Q36320503-685AD138-F8C5-4EC0-94C8-2FB5A50943BAQ36382858-9B90DAEA-014B-4846-BB71-1F2B8FBFD738Q36986153-54666B75-4FE5-4124-916A-CB8AC2D65F4CQ37012676-ABD54E1D-E90A-4C56-BF86-8FC2A9D70A37Q37338982-DCCE4685-00A2-4CAD-9A16-0A1902E11B9FQ37625487-CA33EA68-7A89-4FF3-A8B9-7C89EA1A54AEQ37625491-9296D70B-D89F-4DC4-89F0-965457BB7941Q37652960-21027765-8759-418F-B9FE-7FFF75344D91Q38636569-C32E9377-865B-43FA-A4A5-0FDE2C3F4275Q38892529-FA971A6B-9688-49FB-8C1E-5DED16F3C0B6Q39324374-3D1BA9BA-83AD-44E0-BDF0-E97B312ABAA6Q39467105-B7D1C4F5-AE46-43C2-9CFA-D977482C98D1Q39819715-EC85865F-5920-45B9-953D-9914171E6730Q41196219-F4C0E817-190D-45A7-9E8A-A5A0711C4105Q41758430-B549553C-697E-4FDE-85A5-20D6BF14F2D3Q48217077-C43D755C-E5EC-437B-926E-8E408398A6F1Q48331912-67C5C898-AA72-4DD3-8761-B9E816CEC884Q50791583-E2A37A09-21C8-4303-8DD7-CE6F2C4ECFA3Q53590559-103860FF-BBDD-4562-AC2F-85DA84CCA206Q55405564-DD49E573-6C73-4C5E-ACB6-87324D0996D6
P2860
Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Engagement of CD160 receptor b ...... cells to mediate cytotoxicity
@nl
Engagement of CD160 receptor b ...... cells to mediate cytotoxicity.
@ast
Engagement of CD160 receptor b ...... cells to mediate cytotoxicity.
@en
type
label
Engagement of CD160 receptor b ...... cells to mediate cytotoxicity
@nl
Engagement of CD160 receptor b ...... cells to mediate cytotoxicity.
@ast
Engagement of CD160 receptor b ...... cells to mediate cytotoxicity.
@en
prefLabel
Engagement of CD160 receptor b ...... cells to mediate cytotoxicity
@nl
Engagement of CD160 receptor b ...... cells to mediate cytotoxicity.
@ast
Engagement of CD160 receptor b ...... cells to mediate cytotoxicity.
@en
P2093
P2860
P50
P921
P356
P1476
Engagement of CD160 receptor b ...... cells to mediate cytotoxicity
@en
P2093
Aliz Barakonyi
Anne Marie-Cardine
Fathia Mami-Chouaib
Ivan Hilgert
Laurence Boumsell
Magali Rabot
Maryse Aguerre-Girr
Philippe Le Bouteiller
P2860
P304
16963-16968
P356
10.1073/PNAS.012681099
P407
P577
2002-12-16T00:00:00Z